Effect of HEPA Air Filters on Subclinical Markers of Cardiovascular Health

NCT01256957 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2016-12-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the ability of portable high efficiency particle air (HEPA) filters to reduce exposures to PM2.5 and woodsmoke air pollution indoors and to improve subclinical indicators of microvascular function, systemic inflammation, and oxidative stress among healthy adult participants.

Conditions

  • Endothelial Function
  • Oxidative Stress
  • Systemic Inflammation

Interventions

DEVICE

HEPA filter

Sponsors & Collaborators

  • University of British Columbia

    collaborator OTHER
  • Health Canada

    collaborator OTHER_GOV
  • Ministry of Environment, British Columbia

    collaborator OTHER
  • Simon Fraser University

    lead OTHER

Principal Investigators

  • Ryan Allen, PhD · Simon Fraser University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01256957 on ClinicalTrials.gov